Evoq Remedies Ltd

Evoq Remedies Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Evoq Remedies Ltd

₹ 10.3 -2.19%
29 Apr - close price
evoqremedies.com BSE: 543500
About

Incorporated in 2010, EVOQ Remedies
Ltd is engaged in the trading of pharmaceuticals formulation and allied products[1]

Key Points

Business Overview:[1][2]
Company is in the business of marketing, trading, and distribution of a wide range of pharmaceutical formulation products. Apart from this, the company also deals in trading of active pharmaceutical ingredients, Nutraceutical, Ayurvedic, and Herbal Products

Website BSE
  • Market Cap ₹ 14.0 Cr.
  • Current Price ₹ 10.3
  • High / Low ₹ 19.4 / 8.50
  • Stock P/E 10.3
  • Book Value ₹ 18.3
  • Dividend Yield 0.00 %
  • ROCE 6.97 %
  • ROE 6.76 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 0.56 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -53.0%
  • Promoter holding is low: 20.5%
  • Company has a low return on equity of 9.45% over last 3 years.
  • Earnings include an other income of Rs.6.02 Cr.
  • Company has high debtors of 308 days.
  • Working capital days have increased from 418 days to 612 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023
2.76 4.93 11.85 15.79 4.60 3.90
1.71 4.20 11.12 15.48 8.64 3.83
Operating Profit 1.05 0.73 0.73 0.31 -4.04 0.07
OPM % 38.04% 14.81% 6.16% 1.96% -87.83% 1.79%
0.00 0.00 0.00 0.00 6.02 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 1.05 0.73 0.73 0.31 1.98 0.07
Tax % 22.86% 0.00% 50.68% 0.00% 33.84% 28.57%
0.81 0.73 0.36 0.31 1.31 0.05
EPS in Rs 810.00 730.00 0.26 0.23 0.96 0.04
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
3.25 9.07 10.02 16.78 20.39 8.50
3.23 9.07 9.07 15.32 24.12 12.47
Operating Profit 0.02 0.00 0.95 1.46 -3.73 -3.97
OPM % 0.62% 0.00% 9.48% 8.70% -18.29% -46.71%
0.00 0.00 0.00 0.00 6.02 6.02
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 0.02 0.00 0.95 1.46 2.29 2.05
Tax % 0.00% 25.26% 25.34% 29.26%
0.01 0.00 0.72 1.09 1.62 1.36
EPS in Rs 10.00 0.00 720.00 0.80 1.19 1.00
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 31%
TTM: -69%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 103%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -20%
Return on Equity
10 Years: %
5 Years: %
3 Years: 9%
Last Year: 7%

Balance Sheet

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 0.01 0.01 0.01 13.60 13.60 13.60
Reserves 0.01 0.01 0.73 9.57 11.19 11.24
0.00 0.01 0.00 8.16 9.58 1.28
2.12 5.62 7.30 2.00 0.53 4.69
Total Liabilities 2.14 5.65 8.04 33.33 34.90 30.81
0.00 0.00 0.00 0.00 0.01 0.02
CWIP 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00
2.14 5.65 8.04 33.33 34.89 30.79
Total Assets 2.14 5.65 8.04 33.33 34.90 30.81

Cash Flows

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
0.01 -0.02 0.03 -26.43 -4.35
0.00 0.00 0.00 0.00 -0.01
0.00 0.00 0.00 29.49 1.42
Net Cash Flow 0.01 -0.02 0.03 3.06 -2.94

Ratios

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 138.14 189.94 249.16 552.50 308.25
Inventory Days 3.39 2.42 6.97 20.66 38.33
Days Payable 239.57 226.66 315.25 32.05 -10.20
Cash Conversion Cycle -98.04 -34.30 -59.11 541.11 356.78
Working Capital Days 1.12 1.21 26.23 614.06 612.39
ROCE % 0.00% 246.75% 9.11% 6.97%

Shareholding Pattern

Numbers in percentages

6 Recently
Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024
73.53% 73.53% 73.53% 73.53% 20.53%
26.47% 26.48% 26.47% 26.47% 79.47%
No. of Shareholders 8247277077271,672

Documents

Announcements

Annual reports